Muscle Spasticity Global Market Report 2024

Description

Muscle spasticity is a condition marked by an abnormal increase in muscle tone or stiffness that can disrupt movement and speech. It typically arises from damage to the brain or spinal cord that affects the control of voluntary muscle movements.

The main types of drugs used to treat muscle spasticity include baclofen, botulinum toxin, diazepam, dantrolene sodium, and others. These drugs can be administered via various routes, such as oral and intramuscular. They are distributed through multiple channels, including hospital pharmacies, retail pharmacies, and online pharmacies.

The muscle spasticity market research report is one of a series of new reports from The Business Research Company that provides muscle spasticity market statistics, including the muscle spasticity industry global market size, regional shares, competitors with muscle spasticity market share, detailed muscle spasticity market segments, market trends, and opportunities, and any further data you may need to thrive in the muscle spasticity industry. These muscle spasticity market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The muscle spasticity market size has grown strongly in recent years. It will grow from $3.85 billion in 2023 to $4.19 billion in 2024 at a compound annual growth rate (CAGR) of 8.8%. The growth during the historic period can be attributed to several factors, increased investments in research and development, expansion of clinical indications, favorable regulatory approvals and reimbursement policies, a growing emphasis on adopting a multimodal approach, and a rising prevalence of multiple sclerosis.

The muscle spasticity market size is expected to see strong growth in the next few years. It will grow to $5.89 billion in 2028 at a compound annual growth rate (CAGR) of 8.9%. The anticipated growth during the forecast period can be attributed to several factors, a growing focus on patient-centric care, expansion of distribution channels, efforts to improve quality of life, development of targeted drug delivery systems, and the discovery of biomarkers. Key trends expected to shape the market include the adoption of value-based reimbursement models, integration of artificial intelligence and machine learning technologies, use of telehealth and remote monitoring technologies, advances in neurostimulation techniques, and the application of regenerative medicine approaches.

The increasing prevalence of musculoskeletal disorders is expected to boost the growth of the muscle spasticity market. Musculoskeletal disorders affect the muscles, bones, and joints, often leading to pain, stiffness, and restricted movement. Factors contributing to the rise in these disorders include aging populations, sedentary lifestyles, and a higher incidence of chronic conditions. Muscle spasticity treatments aim to reduce pain, enhance mobility, prevent complications, and improve the overall quality of life and functional abilities of patients. For example, a study published by The Lancet in November 2023 estimated that 494 million people worldwide experienced musculoskeletal disorders in 2020, with a projected increase of 115% by 2050. Additionally, Amgen reported in May 2022 that fractures due to osteoporosis are expected to rise by 68%, from 1.9 million in 2018 to 3.2 million by 2040. This growing prevalence of musculoskeletal disorders is driving the muscle spasticity market.

Key players in the muscle spasticity market are focusing on developing oral suspensions to treat muscle spasms caused by conditions such as multiple sclerosis and spinal cord injuries. Oral suspensions are liquid medications with active ingredients dispersed for oral consumption. For instance, ANI Pharmaceuticals, a US-based pharmaceutical company, introduced baclofen oral suspension in April 2024. This product, a generic version of Fleqsuvy, is designed to treat muscle spasms by helping to relax the muscles in conditions such as multiple sclerosis and spinal cord injuries.

In January 2022, Amneal Pharmaceuticals Inc., a US-based pharmaceutical manufacturer, acquired the baclofen franchise from Saol Therapeutics, including products such as Lioresal and Lyvispah. This $83.5 million acquisition aims to strengthen Amneal Pharmaceuticals' neurology portfolio and enhance its presence in the institutional market. It also supports Amneal's entry into the biosimilar market, with expected revenue growth from the baclofen franchise by 2025. Saol Therapeutics is a US-based company specializing in developing treatments for limb spasticity and pain related to knee osteoarthritis.

Major companies operating in the muscle spasticity market are F. Hoffmann-La Roche AG, AbbVie Inc., Abbott Laboratories, Novartis AG, Medtronic plc, Teva Pharmaceutical Industries Ltd., Boston Scientific Corporation, Sun Pharmaceutical Industries Ltd., Ipsen Pharma, Hikma Pharmaceuticals plc, Endo Pharmaceuticals Inc., Lupin Pharmaceuticals Inc., Amneal Pharmaceuticals Inc., Mallinckrodt Pharmaceuticals, Neurocrine Biosciences Inc., Merz Pharmaceuticals GmbH, Beximco Pharmaceuticals Ltd., ANI Pharmaceuticals Inc., Taj Pharmaceuticals Limited, Revance Therapeutics Inc., Acorda Therapeutics Inc., Mylan N.V., Camber Pharmaceuticals Inc., Saol Therapeutics Inc., Zydus Cadila

North America was the largest region in the muscle spasticity market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the muscle spasticity market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the muscle spasticity market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The muscle spasticity market consists of revenues earned by entities by providing services such as pharmaceutical treatments, physical therapy, and occupational therapy. The market value includes the value of related goods sold by the service provider or included within the service offering. The muscle spasticity market also includes sales of tizanidine, gabapentin, and pregabalin. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Muscle Spasticity Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on muscle spasticity market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for muscle spasticity ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The muscle spasticity market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Drug Type: Baclofen; Botulinum Toxin; Diazepam; Dantrolene Sodium; Other Drugs
2) By Route Of Administration: Oral; Intramuscular; Other Routes
3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
Companies Mentioned: F. Hoffmann-La Roche AG; AbbVie Inc.; Abbott Laboratories; Novartis AG; Medtronic plc
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r19725

1. Executive Summary

2. Muscle Spasticity Market Characteristics

3. Muscle Spasticity Market Trends And Strategies

4. Muscle Spasticity Market - Macro Economic Scenario

4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market

5. Global Muscle Spasticity Market Size and Growth

5.1. Global Muscle Spasticity Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global Muscle Spasticity Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Muscle Spasticity Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Muscle Spasticity Market Segmentation

6.1. Global Muscle Spasticity Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Baclofen
Botulinum Toxin
Diazepam
Dantrolene Sodium
Other Drugs
6.2. Global Muscle Spasticity Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Oral
Intramuscular
Other Routes
6.3. Global Muscle Spasticity Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

7. Muscle Spasticity Market Regional And Country Analysis

7.1. Global Muscle Spasticity Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Muscle Spasticity Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Muscle Spasticity Market

8.1. Asia-Pacific Muscle Spasticity Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Muscle Spasticity Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Muscle Spasticity Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Muscle Spasticity Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Muscle Spasticity Market

9.1. China Muscle Spasticity Market Overview
9.2. China Muscle Spasticity Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Muscle Spasticity Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Muscle Spasticity Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Muscle Spasticity Market

10.1. India Muscle Spasticity Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Muscle Spasticity Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Muscle Spasticity Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Muscle Spasticity Market

11.1. Japan Muscle Spasticity Market Overview
11.2. Japan Muscle Spasticity Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Muscle Spasticity Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Muscle Spasticity Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Muscle Spasticity Market

12.1. Australia Muscle Spasticity Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Muscle Spasticity Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Muscle Spasticity Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Muscle Spasticity Market

13.1. Indonesia Muscle Spasticity Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Muscle Spasticity Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Muscle Spasticity Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Muscle Spasticity Market

14.1. South Korea Muscle Spasticity Market Overview
14.2. South Korea Muscle Spasticity Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Muscle Spasticity Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Muscle Spasticity Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Muscle Spasticity Market

15.1. Western Europe Muscle Spasticity Market Overview
15.2. Western Europe Muscle Spasticity Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Muscle Spasticity Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Muscle Spasticity Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Muscle Spasticity Market

16.1. UK Muscle Spasticity Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Muscle Spasticity Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Muscle Spasticity Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Muscle Spasticity Market

17.1. Germany Muscle Spasticity Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Muscle Spasticity Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Muscle Spasticity Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Muscle Spasticity Market

18.1. France Muscle Spasticity Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Muscle Spasticity Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Muscle Spasticity Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Muscle Spasticity Market

19.1. Italy Muscle Spasticity Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Muscle Spasticity Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Muscle Spasticity Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Muscle Spasticity Market

20.1. Spain Muscle Spasticity Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Muscle Spasticity Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Muscle Spasticity Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Muscle Spasticity Market

21.1. Eastern Europe Muscle Spasticity Market Overview
21.2. Eastern Europe Muscle Spasticity Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Muscle Spasticity Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Muscle Spasticity Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Muscle Spasticity Market

22.1. Russia Muscle Spasticity Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Muscle Spasticity Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Muscle Spasticity Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Muscle Spasticity Market

23.1. North America Muscle Spasticity Market Overview
23.2. North America Muscle Spasticity Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Muscle Spasticity Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Muscle Spasticity Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Muscle Spasticity Market

24.1. USA Muscle Spasticity Market Overview
24.2. USA Muscle Spasticity Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Muscle Spasticity Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Muscle Spasticity Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Muscle Spasticity Market

25.1. Canada Muscle Spasticity Market Overview
25.2. Canada Muscle Spasticity Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Muscle Spasticity Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Muscle Spasticity Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Muscle Spasticity Market

26.1. South America Muscle Spasticity Market Overview
26.2. South America Muscle Spasticity Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Muscle Spasticity Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Muscle Spasticity Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Muscle Spasticity Market

27.1. Brazil Muscle Spasticity Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Muscle Spasticity Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Muscle Spasticity Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Muscle Spasticity Market

28.1. Middle East Muscle Spasticity Market Overview
28.2. Middle East Muscle Spasticity Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Muscle Spasticity Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Muscle Spasticity Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Muscle Spasticity Market

29.1. Africa Muscle Spasticity Market Overview
29.2. Africa Muscle Spasticity Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Muscle Spasticity Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Muscle Spasticity Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Muscle Spasticity Market Competitive Landscape And Company Profiles

30.1. Muscle Spasticity Market Competitive Landscape
30.2. Muscle Spasticity Market Company Profiles
- 30.2.1. F. Hoffmann-La Roche AG
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. AbbVie Inc.
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. Abbott Laboratories
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. Novartis AG
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. Medtronic plc
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. Muscle Spasticity Market Other Major And Innovative Companies

31.1. Teva Pharmaceutical Industries Ltd.
31.2. Boston Scientific Corporation
31.3. Sun Pharmaceutical Industries Ltd.
31.4. Ipsen Pharma
31.5. Hikma Pharmaceuticals plc
31.6. Endo Pharmaceuticals Inc.
31.7. Lupin Pharmaceuticals Inc.
31.8. Amneal Pharmaceuticals Inc.
31.9. Mallinckrodt Pharmaceuticals
31.10. Neurocrine Biosciences Inc.
31.11. Merz Pharmaceuticals GmbH
31.12. Beximco Pharmaceuticals Ltd.
31.13. ANI Pharmaceuticals Inc.
31.14. Taj Pharmaceuticals Limited
31.15. Revance Therapeutics Inc.

32. Global Muscle Spasticity Market Competitive Benchmarking

33. Global Muscle Spasticity Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Muscle Spasticity Market

35. Muscle Spasticity Market Future Outlook and Potential Analysis

35.1 Muscle Spasticity Market In 2028 - Countries Offering Most New Opportunities
35.2 Muscle Spasticity Market In 2028 - Segments Offering Most New Opportunities
35.3 Muscle Spasticity Market In 2028 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer